Shortly after [posting my latest tumor board presentation][cmc8], I discovered that someone is making a documentary about men with breast cancer. The preview looked interesting.

As the year winds down, these tumor board presentations will get less frequent. For now, though, it is still once a month. My latest, on breast cancer in men, seemed to be well-received. I suspect it was because, unlike most rare cancers, this one was easy to fit into a preexisting pattern: it is just like female breast cancer, except for… And voilà—you get quick and easily understood knowledge about a whole new disease entity.

The field of breast cancer research is nothing if not full of highly-powered, multicenter, seemingly decades-long trials. Which is good, since there are many questions that need answering.

If the unstated goal of these rotation post-mortems was to summarize what I had learned, a single post may not be enough for breast cancer. Six weeks ago, I knew that it was common, maybe overdiagnosed, possibly overtreated, and beating all other cancers for research funding by a vast margin …